Barclays PLC Form 8.5 (EPT/NON-RI) Clinigen Group plc (1236H)
04 Abril 2022 - 3:50AM
UK Regulatory
TIDMBARC TIDMCLIN
RNS Number : 1236H
Barclays PLC
04 April 2022
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY
("RI") STATUS
(OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal BARCLAYS CAPITAL SECURITIES LTD
trader:
---------------------------------
(b) Name of offeror/offeree in CLINIGEN GROUP PLC
relation to whose
-----------------------------------------
relevant securities this
form relates:
---- --------------------------------- -------------------------------------
(c) Name of the party to the Triley Bidco Limited (a newly-formed
offer with which exempt company indirectly owned by Triton
Funds)
-----------------------------------------
principal trader is connected
---- ------------------------------- -------------------------------------
(d) Date position held/dealing 01 April 2022
undertaken:
---- --------------------------------- -----------------------------------------
(e) In addition to the company NO
in 1(b) above, is the exempt
principal
trader making disclosures
in respect of any other party
to the offer?
---- --------------------------------- -------------------------------------
2. POSITIONS OF THE EXEMPT
PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities
of the offeror or offeree
to which the disclosure relates following the dealing
(if any)
Class of relevant security: 0.1p ordinary
------------------- -------------------
Interests Short Positions
------------------- -------------------
Number (%) Number (%)
------------------------------------------------- ---------- ------- ----------- ------
(1) Relevant securities owned
and/or controlled: 1,312,282 0.98% 541,332 0.41%
(2) Cash-settled derivatives:
541,332 0.41% 1,305,123 0.98%
(3) Stock-settled derivatives
(including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,853,614 1.39% 1,846,455 1.38%
(b) Rights to subscribe for new securities (including
directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
-------------------------------------------------------------------- -------
Details, including nature of the rights
concerned and relevant percentages:
---------------------------------------------------------------------- -------
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL
TRADER
(a) Purchases and
sales
------------------ ---------------- -------------- -------------- --------------
Class of relevant Purchase/sale Total number Highest price Lowest price
of per unit per unit
security securities paid/received paid/received
------------------ -------------- -------------- -------------- --------------
0.1p ordinary Purchase 18,161 9.2495 GBP 9.2463 GBP
---------------- ---------------- -------------- --------------
0.1p ordinary Sale 22,873 9.2518 GBP 9.245 GBP
---------------- ---------------- -------------- --------------
(b) Cash-settled derivative transactions
-------------- ----------------------------------------------------- -----------
Class of Product Nature of Number Price per
dealing of
relevant description reference unit
security securities
-------------- -------------- ----------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 221 9.2500 GBP
---------------- ------------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 605 9.2450 GBP
---------------- ------------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 871 9.2480 GBP
---------------- ------------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 5,354 9.2500 GBP
---------------- ------------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 7,084 9.2450 GBP
---------------- ------------------- ------------ -----------
0.1p ordinary SWAP Decreasing Short 7,771 9.2490 GBP
---------------- ------------------- ------------ -----------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or
varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying to received
etc which
option per unit
relates
------------- -------------- ------------ -------------- ----- ------------ -----------
(ii) Exercising
Class of relevant Product description Exercising/ Number Exercise
exercised against of price per
security securities unit
-------------- ------------- -------------- ------------ ------------ -----------
(d) Other dealings (including subscribing for new securities)
Class Nature Details Price
of relevant of Dealings per unit
(if
security applicable)
-------------- ------------- -------------- ------------ ------------ -----------
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement
or understanding,
formal or informal, relating to relevant securities which may
be an inducement to deal
or refrain from dealing entered into by the exempt principal
trader making the disclosure and any party
to the offer or any person acting in concert with a party to
the offer:
-------------------------------------------------------------------------------------------------------------
NONE
-------------------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating
to options or derivatives
Details of any agreement, arrangement or understanding, formal
or informal, between
the exempt principal trader making the disclosure and any other
person relating to:
(i) the voting rights of any relevant securities under any option;
or
(ii) the voting rights of future acquisition or disposal of
any relevant securities to which
any derivative is referenced:
----------------------------------------------------------- -------------- ----- ------------ -----------
NONE
-------------------------------------------------------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open NO
Positions) attached?
------------------------------------------------
Date of disclosure: 4 Apr 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
--------------------- ------------ -----------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FEOBKQBQFBKKOQK
(END) Dow Jones Newswires
April 04, 2022 04:50 ET (08:50 GMT)
Clinigen (LSE:CLIN)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Clinigen (LSE:CLIN)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
